DANIEL LEARY: Open Payments
NPI 1740748235 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,931 in 107 payments from 17 companies in 2025. Trend: 2023 $557 · 2024 $2,265 · 2025 $1,931
Food & beverage: $1,831Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $456 |
| LEO Pharma Inc. | 14 | $382 |
| Janssen Biotech, Inc. | 16 | $266 |
| Regeneron Healthcare Solutions, Inc. | 4 | $120 |
| Galderma Laboratories, L.P. | 6 | $118 |
| E.R. Squibb & Sons, L.L.C. | 4 | $98 |
| GENZYME CORPORATION | 3 | $88 |
| PFIZER INC. | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| Organon LLC | 3 | $66 |
Products named: ADBRY, TREMFYA, RINVOQ, SKYRIZI, Sotyktu, DUPIXENT, ANZUPGO, NEMLUVIO.
Industry payments across MA — which companies pay providers there.
